Spokesperson Portfolio - John T. Brooks, MD
Medical Epidemiologist, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention.
Video: Managing Fear
“To understand an epidemic, you often need the 35,000-foot view, looking for trends and patterns.” says Dr. John Brooks. “But you also need to find out what’s going on at ground level, what’s happening to the people at risk of, and being affected by, the condition you’re trying to prevent.” This is how Brooks approaches his work to improve prevention and treatment for HIV-affected people, and how he approached his role in helping the public understand the science behind how to prevent Ebola transmission during the 2014 Ebola response.
CDC Public Affairs
John T. Brooks, MD Cdc-pdf[PDF – 477 KB]
- HIV/AIDS prevention and treatment
- Ebola prevention and treatment
- Infectious diseases
- Medical Epidemiologist, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
- Team Leader, CDC Hurricane Katrina Response Unit
- Team Leader, CDC SARS Response Unit
- Team Leader, CDC Anthrax Response Unit
- Medical Epidemiologist, Foodborne and Diarrheal Disease Branch, National Center for Infectious Diseases
- Epidemic Intelligence Service Officer, 1998-2000
- Wesleyan University (BA with honors) in Earth Science and German
- University of Heidelberg, Heidelberg, Germany (Fellow, Institute for Sediment Research)
- Harvard Medical School (MD)
- Internal Medicine Residency, Brigham and Women’s Hospital
- Infectious Diseases Fellowship, Harvard Joint Program
- Clinical Assistant Professor, Emory University School of Medicine
Honors and Awards
- Phi Beta Kappa
- Sigma Xi
- Secretary of Health and Human Services Awards for Distinguished Service
- Outstanding Unit Citations while a member of the U.S. Commissioned Corps
- Crisis Response Awards while a member of the U.S. Commissioned Corps
- October 27, 2014 – Ebola Teams Train To Respond To New U.S. Cases At A Moment’s NoticeExternal
- October 20, 2014 – Inside the CDC: Exclusive look at what’s being done to fight EbolaExternal
- October 16, 2014 – CDC director’s challenge: Deadly Ebola virus and outbreak of criticismExternal
- August 9, 2014 – Why HIV Patients Must Stop SmokingExternal
- Joyce MP, Kuhar D, Brooks JT, “Notes from the Field: Occupationally Acquired HIV Infection Among Health Care Workers – United States, 1985-2013.”, Morbidity and Mortality Weekly Report, 63(53):1245-6, 2014
- Brooks JT, Buchacz K, Gebo K, and Mermin J, “Aging and HIV Infection: The Public Health Perspective”, American Journal of Public Health, 102(8): 1516-1526, 2012.
- Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Segolodi TM, Soud FA, Henderson FL, Pathak SR, Rose CE, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, and Brooks JT for the TDF2 Study Group, “Safety and Efficacy of Daily Oral Antiretroviral Use for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana: the TDF2 Study”, New England Journal of Medicine, 367:423-434, 2012.
- Althoff KN, Buchacz K, Hall I, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg M, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne J, Crane H, Mugavero1 MJ, Napravnik S, Rodriguez B, Kirk GD, Anastos K, Jacobson LP, and Brooks JT for The North American AIDS Cohort Collaboration on Research and Design, “Trends in antiretroviral therapy use, HIV RNA plasma viral loads and CD4 T-lymphocyte counts among human immunodeficiency virus (HIV)-infected persons in care in the United States, 2000-2008”, Annals of Internal Medicine, 157(5):325-335, 2012.
- Brooks JT, “The importance of a complete sexual history for HIV-infected adults: reducing risk and improving health”, Clinical Issues in HIV Medicine; v-vi, 2009.
- Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H, “HIV-associated opportunistic infections: going, going but not gone. The continued need for prevention and treatment guidelines”, Clinical Infectious Diseases, 48(5):609-11, 2009.
- Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Hoekstra RM, Strockbine NA, “Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002”, Journal of Infectious Diseases, 192(8): 1422-9, 2005.